triphenylsilanol | CAS:791-31-1-or-16527-35-8

We serve triphenylsilanol CAS:791-31-1-or-16527-35-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
triphenylsilanol

Chemical Name:triphenylsilanol
CAS.NO:791-31-1;16527-35-8
Synonyms:Triphenylsilanol; triphenyl-silano; Silanol, triphenyl-; hydroxytriphenyl-silan; Silanol,triphenyl;
Molecular Formula:C18H16OSi
Molecular Weight:276.40500
 
Physical and Chemical Properties:
Density:1.13;
Melting point:150-153oC;
Boiling point:389oC;
Flash point:190oC;
Index of Refraction:1.628;
 
Specification:
Appearance:White crystal
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It is used in the pharmaceutical and chemical industry.



Contact us for information like triphenylsilanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Silanol,triphenyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,hydroxytriphenyl-silan Use and application,triphenyl-silano technical grade,usp/ep/jp grade.


Related News: Australia has started denying entry to all travelers who have come from or transited through mainland China.1-Benzhydrylazetidin-3-One manufacturer Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.3-Bromoaniline supplier As of Friday, the virus had claimed the lives of more than 250 people in mainland China.3-bromodibenzofuran vendor Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.